Oncotelic Therapeutics Statistics
Total Valuation
OTLC has a market cap or net worth of 24.83 million. The enterprise value is 38.01 million.
| Market Cap | 24.83M |
| Enterprise Value | 38.01M |
Important Dates
The last earnings date was Monday, April 27, 2026.
| Earnings Date | Apr 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OTLC has 443.48 million shares outstanding. The number of shares has increased by 5.84% in one year.
| Current Share Class | 443.48M |
| Shares Outstanding | 443.48M |
| Shares Change (YoY) | +5.84% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 44.08% |
| Owned by Institutions (%) | n/a |
| Float | 227.90M |
Valuation Ratios
The trailing PE ratio is 0.10.
| PE Ratio | 0.10 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.09 |
| P/TBV Ratio | 0.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.15 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11, with a Debt / Equity ratio of 0.05.
| Current Ratio | 0.11 |
| Quick Ratio | 0.00 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.85 |
Financial Efficiency
Return on equity (ROE) is 183.49% and return on invested capital (ROIC) is -1.18%.
| Return on Equity (ROE) | 183.49% |
| Return on Assets (ROA) | -1.41% |
| Return on Invested Capital (ROIC) | -1.18% |
| Return on Capital Employed (ROCE) | -1.26% |
| Weighted Average Cost of Capital (WACC) | 2.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 6.03M |
| Employee Count | 43 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, OTLC has paid 111.55 million in taxes.
| Income Tax | 111.55M |
| Effective Tax Rate | 31.10% |
Stock Price Statistics
The stock price has decreased by -6.67% in the last 52 weeks. The beta is -0.54, so OTLC's price volatility has been lower than the market average.
| Beta (5Y) | -0.54 |
| 52-Week Price Change | -6.67% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 75.59 |
| Average Volume (20 Days) | 343,233 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.74M |
| Pretax Income | 358.70M |
| Net Income | 247.38M |
| EBITDA | n/a |
| EBIT | -4.74M |
| Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 63,614 in cash and 14.31 million in debt, with a net cash position of -14.25 million or -0.03 per share.
| Cash & Cash Equivalents | 63,614 |
| Total Debt | 14.31M |
| Net Cash | -14.25M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 262.21M |
| Book Value Per Share | 0.59 |
| Working Capital | -16.34M |
Cash Flow
| Operating Cash Flow | -1.56M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.54M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OTLC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.84% |
| Shareholder Yield | -5.84% |
| Earnings Yield | 996.12% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |